Literature DB >> 26278577

Second-Line Chemotherapy in Recurrent Glioblastoma--Still Controversial.

Enrico Franceschi1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26278577     DOI: 10.1159/000435903

Source DB:  PubMed          Journal:  Oncol Res Treat        ISSN: 2296-5270            Impact factor:   2.825


× No keyword cloud information.
  1 in total

1.  Does a Bevacizumab-based regime have a role in the treatment of children with diffuse intrinsic pontine glioma? A systematic review.

Authors:  Mia Evans; Ria Gill; Kim S Bull
Journal:  Neurooncol Adv       Date:  2022-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.